ciprofloxacin has been researched along with alvocidib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Karthikeyan, S; Palakshi Reddy, B; Rajesh, K; Suchetha Kumari, N; Venkat Ragavan, R; Vijayakumar, V | 1 |
3 other study(ies) available for ciprofloxacin and alvocidib
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Simple, fast and efficient synthesis of β-keto esters from the esters of heteroaryl compounds, its antimicrobial study and cytotoxicity towards various cancer cell lines.
Topics: Acetates; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esters; Fungi; Humans; Inhibitory Concentration 50; Ketones; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Solvents; Structure-Activity Relationship | 2012 |